You are here

Optical Based Imaging for Protein Crystal Diagnostics

Award Information
Agency: National Aeronautics and Space Administration
Branch: N/A
Contract: N/A
Agency Tracking Number: NASA594
Amount: $69,900.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2001
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
102A Wynn Drive
Huntsville, AL 35805
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Blair Barbour
 President
 (256) 704-3416
 Blair@Photon-X.com
Business Contact
 Blair Barbour
Title: President
Phone: (256) 704-3416
Email: Blair@Photon-X.com
Research Institution
N/A
Abstract

Photon-X has developed a patented imaging process which could potentially reduce the burden on X-ray crystallography and potential provide a tool to monitor in real-time the growth of each crystal to provide maximum efficiency and to grow more perfect crystals effortlessly. The Photon-X imaging technology is called spatial phase imaging. Photon-X's three innovations are one identifying protein crystals in a solution, two identifying the quality of the crystals grown and three in situ protein crystal growth diagnostic tool.It is not unusual to set up hundreds or even thousands of crystallization solutions at a time, at different conditions when doing initial crystallization trials or when refining known conditions for any given protein. In industrial or commercial cases, up to hundreds of thousands of solutions being set up in some cases. Repeated examination of these numbers of solutions for just one protein is too much for any one or group of people to keep up with, and the problem becomes considerably greater when one considers that most structural laboratories are working on several proteins at any one time. Pharmaceutical company laboratories are working on many proteins at any one time, making the problem even greater in their case. A robotic optical imaging solution is needed to setup and monitor crystal growth of many varieties of crystals. The commercial potential of such a device could increase drug therapy by orders of magnitude.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government